Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1151 | 2720 | 39.5 | 72% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SUBLINGUAL IMMUNOTHERAPY | Author keyword | 500 | 77% | 12% | 336 |
| 2 | SUBCUTANEOUS IMMUNOTHERAPY | Author keyword | 139 | 80% | 3% | 87 |
| 3 | SPECIFIC IMMUNOTHERAPY | Author keyword | 130 | 48% | 7% | 196 |
| 4 | ALLERGEN IMMUNOTHERAPY | Author keyword | 125 | 67% | 4% | 114 |
| 5 | ALLERGEN SPECIFIC IMMUNOTHERAPY | Author keyword | 72 | 55% | 3% | 91 |
| 6 | LOCAL NASAL IMMUNOTHERAPY | Author keyword | 64 | 100% | 1% | 21 |
| 7 | ALLERGOID | Author keyword | 58 | 86% | 1% | 30 |
| 8 | ALLERGOIDS | Author keyword | 55 | 92% | 1% | 22 |
| 9 | GRASS POLLEN | Author keyword | 36 | 37% | 3% | 78 |
| 10 | CLUSTER IMMUNOTHERAPY | Author keyword | 33 | 83% | 1% | 19 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SUBLINGUAL IMMUNOTHERAPY | 500 | 77% | 12% | 336 | Search SUBLINGUAL+IMMUNOTHERAPY | Search SUBLINGUAL+IMMUNOTHERAPY |
| 2 | SUBCUTANEOUS IMMUNOTHERAPY | 139 | 80% | 3% | 87 | Search SUBCUTANEOUS+IMMUNOTHERAPY | Search SUBCUTANEOUS+IMMUNOTHERAPY |
| 3 | SPECIFIC IMMUNOTHERAPY | 130 | 48% | 7% | 196 | Search SPECIFIC+IMMUNOTHERAPY | Search SPECIFIC+IMMUNOTHERAPY |
| 4 | ALLERGEN IMMUNOTHERAPY | 125 | 67% | 4% | 114 | Search ALLERGEN+IMMUNOTHERAPY | Search ALLERGEN+IMMUNOTHERAPY |
| 5 | ALLERGEN SPECIFIC IMMUNOTHERAPY | 72 | 55% | 3% | 91 | Search ALLERGEN+SPECIFIC+IMMUNOTHERAPY | Search ALLERGEN+SPECIFIC+IMMUNOTHERAPY |
| 6 | LOCAL NASAL IMMUNOTHERAPY | 64 | 100% | 1% | 21 | Search LOCAL+NASAL+IMMUNOTHERAPY | Search LOCAL+NASAL+IMMUNOTHERAPY |
| 7 | ALLERGOID | 58 | 86% | 1% | 30 | Search ALLERGOID | Search ALLERGOID |
| 8 | ALLERGOIDS | 55 | 92% | 1% | 22 | Search ALLERGOIDS | Search ALLERGOIDS |
| 9 | GRASS POLLEN | 36 | 37% | 3% | 78 | Search GRASS+POLLEN | Search GRASS+POLLEN |
| 10 | CLUSTER IMMUNOTHERAPY | 33 | 83% | 1% | 19 | Search CLUSTER+IMMUNOTHERAPY | Search CLUSTER+IMMUNOTHERAPY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SWALLOW IMMUNOTHERAPY | 439 | 96% | 5% | 138 |
| 2 | GRASS POLLEN IMMUNOTHERAPY | 369 | 64% | 13% | 361 |
| 3 | SUBLINGUAL IMMUNOTHERAPY | 256 | 51% | 13% | 361 |
| 4 | DERMATOPHAGOIDES PTERONYSSINUS EXTRACT | 192 | 86% | 4% | 96 |
| 5 | STANDARDIZED 5 GRASS POLLEN EXTRACT | 163 | 96% | 2% | 50 |
| 6 | ALLERGEN SPECIFIC IMMUNOTHERAPY | 111 | 57% | 5% | 133 |
| 7 | SYSTEMIC REACTIONS | 103 | 60% | 4% | 112 |
| 8 | ALLERGEN IMMUNOTHERAPY | 102 | 66% | 3% | 95 |
| 9 | HYPOSENSITIZATION | 86 | 53% | 4% | 114 |
| 10 | SUBLINGUAL SWALLOW IMMUNOTHERAPY | 86 | 82% | 2% | 50 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma A Systematic Review | 2013 | 61 | 70 | 94% |
| Effectiveness of Subcutaneous Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: A Systematic Review | 2014 | 21 | 64 | 92% |
| Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile | 2012 | 74 | 29 | 76% |
| Systematic reviews of sublingual immunotherapy (SLIT) | 2011 | 86 | 63 | 94% |
| Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: A systematic review and indirect comparison | 2013 | 44 | 22 | 77% |
| Subcutaneous Immunotherapy Versus Sublingual Immunotherapy: Which Is More Effective? | 2014 | 13 | 42 | 100% |
| Sub-lingual Immunotherapy: World Allergy Organization Position Paper 2009 | 2009 | 141 | 272 | 76% |
| Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review | 2015 | 2 | 25 | 72% |
| Allergen injection immunotherapy for seasonal allergic rhinitis | 2007 | 175 | 182 | 80% |
| Injection allergen immunotherapy for asthma | 2010 | 68 | 211 | 91% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RHINOL ALLERGOL WIESBADEN | 21 | 90% | 0.3% | 9 |
| 2 | SECT ALLERGY CLIN IMMUNOL | 13 | 33% | 1.2% | 33 |
| 3 | ALLERGY UNIT 7551 | 8 | 75% | 0.2% | 6 |
| 4 | RHINOL ALLERGOL | 7 | 57% | 0.3% | 8 |
| 5 | ALLERGY RHEUMATOL UNIT | 7 | 67% | 0.2% | 6 |
| 6 | UNIT EXPT IMMUNOTHER Y | 6 | 45% | 0.4% | 10 |
| 7 | DIMI CEBR | 6 | 100% | 0.1% | 4 |
| 8 | DIMI | 5 | 11% | 1.5% | 40 |
| 9 | VIENNA CHALLENGE CHAMBER | 4 | 67% | 0.1% | 4 |
| 10 | GRP CLIN DEV | 4 | 75% | 0.1% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000122059 | VENOM IMMUNOTHERAPY//HYMENOPTERA VENOM ALLERGY//STING CHALLENGE |
| 2 | 0.0000108040 | BET V 1//ORAL ALLERGY SYNDROME//RECOMBINANT ALLERGEN |
| 3 | 0.0000105347 | ALLERGIC RHINITIS//INTRANASAL CORTICOSTEROIDS//SEASONAL ALLERGIC RHINITIS |
| 4 | 0.0000086777 | SKIN PRICK TEST//PHADIATOP//ALLERGY SCREENING |
| 5 | 0.0000085888 | ALLERGEN FRAGMENTS//AMPLIFICATION FREE//H2 GENOTYPE |
| 6 | 0.0000075204 | BLOMIA TROPICALIS//LEPIDOGLYPHUS DESTRUCTOR//STORAGE MITES |
| 7 | 0.0000061309 | LABORATORY ANIMAL ALLERGY//ANIMAL ALLERGY//MEAT ALLERGY |
| 8 | 0.0000051185 | OMALIZUMAB//ANTI IGE//ANTI IMMUNOGLOBULIN E |
| 9 | 0.0000045826 | IGG SUBCLASSES//MONOGRAPHS IN ALLERGY//IGG SUBCLASS |
| 10 | 0.0000043468 | INDOOR ALLERGENS//HOUSE DUST MITES//BLA G 1 |